Kathleen Laporte - Jul 17, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Director
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
Stock symbol
ETNB
Transactions as of
Jul 17, 2023
Transactions value $
-$202,000
Form type
4
Date filed
7/18/2023, 06:04 PM
Previous filing
Jun 14, 2023
Next filing
Sep 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $33K +12.5K $2.64* 12.5K Jul 17, 2023 Direct
transaction ETNB Common Stock Sale -$235K -12.5K -100% $18.80 0 Jul 17, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -12.5K -50% $0.00 12.5K Jul 17, 2023 Common Stock 12.5K $2.64 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $18.77 to $18.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option is vested in full.